Search Results - "D'OFFIZI, Gianpiero"

Refine Results
  1. 1

    Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs by Minosse, Claudia, Gruber, Cesare E. M., Rueca, Martina, Taibi, Chiara, Zaccarelli, Mauro, Grilli, Elisabetta, Montalbano, Marzia, Capobianchi, Maria R., Antinori, Andrea, D’Offizi, Gianpiero, McPhee, Fiona, Garbuglia, Anna Rosa

    Published in Viruses (16-06-2021)
    “…The risk of hepatitis C virus (HCV) recurrence after direct-acting antiviral (DAA) treatment is <0.5%. However, the distinction between HCV RNA late relapse…”
    Get full text
    Journal Article
  2. 2

    Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections by Minosse, Claudia, Lapa, Daniele, Coppola, Antonio, Rapagna, Federica, D'Offizi, Gianpiero, Taibi, Chiara, Lionetti, Raffaella, Capobianchi, Maria Rosaria, McPhee, Fiona, Garbuglia, Anna Rosa

    Published in Viruses (03-02-2021)
    “…European Association of the Study of the Liver (EASL) guidelines specify HEV RNA, as well as anti-HEV IgG and IgM as positive markers for acute HEV infection…”
    Get full text
    Journal Article
  3. 3

    Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? by Del Nonno, Franca, Nardacci, Roberta, Colombo, Daniele, Visco-Comandini, Ubaldo, Cicalini, Stefania, Antinori, Andrea, Marchioni, Luisa, D’Offizi, Gianpiero, Piacentini, Mauro, Falasca, Laura

    Published in Cells (Basel, Switzerland) (04-05-2021)
    “…Liver injury in COVID-19 patients has progressively emerged, even in those without a history of liver disease, yet the mechanism of liver pathogenicity is…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Clinical Characteristics of Acute Hepatitis E and Their Correlation with HEV Genotype 3 Subtypes in Italy by Minosse, Claudia, Biliotti, Elisa, Lapa, Daniele, Rianda, Alessia, Marchili, Mauro, Luzzitelli, Ilaria, Capobianchi, Maria Rosaria, McPhee, Fiona, Garbuglia, Anna Rosa, D’Offizi, Gianpiero

    Published in Pathogens (Basel) (11-10-2020)
    “…Genotype 3 (GT3) is responsible for most European autochthonous hepatitis E virus (HEV) infections. This study analyzed circulating genotypes and GT3 subtypes…”
    Get full text
    Journal Article
  10. 10

    Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations by Rozera, Gabriella, Abbate, Isabella, Bruselles, Alessandro, Vlassi, Crhysoula, D'Offizi, Gianpiero, Narciso, Pasquale, Chillemi, Giovanni, Prosperi, Mattia, Ippolito, Giuseppe, Capobianchi, Maria R

    Published in Retrovirology (12-02-2009)
    “…Virus-associated cell membrane proteins acquired by HIV-1 during budding may give information on the cellular source of circulating virions. In the present…”
    Get full text
    Journal Article
  11. 11

    Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy by Minosse, Claudia, Salichos, Leonidas, Taibi, Chiara, Luzzitelli, Ilaria, Nardozi, Daniela, Capobianchi, Maria Rosaria, D’Offizi, Gianpiero, McPhee, Fiona, Garbuglia, Anna Rosa

    Published in Microorganisms (Basel) (02-07-2021)
    “…Approximately 71 million people worldwide are infected with the hepatitis C virus (HCV). Injectable drug use represents the most common route of transmission…”
    Get full text
    Journal Article
  12. 12

    TREATMENT OF HEPATITIS C VIRUS INFECTION IN ITALY: A CONSENSUS REPORT FROM AN EXPERT PANEL by Viganò, M, Perno, C.F, Craxì, A

    Published in Digestive and liver disease (01-07-2017)
    “…Abstract Hepatitis C virus (HCV) infection remains one of the main causes of chronic liver disease worldwide. The advent of direct-acting antivirals (DAAs) has…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Timely HAART initiation may pave the way for a better viral control by Paci, Paola, Martini, Federico, Bernaschi, Massimo, D'Offizi, Gianpiero, Castiglione, Filippo

    Published in BMC infectious diseases (01-03-2011)
    “…When to initiate antiretroviral therapy in HIV infected patients is a difficult clinical decision. Actually, it is still a matter of discussion whether early…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Activation of Vγ9Vδ2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication by Agrati, Chiara, Alonzi, Tonino, De Santis, Rafaella, Castilletti, Concetta, Abbate, Isabella, Capobianchi, Maria Rosaria, D'Offizi, Gianpiero, Siepi, Francesca, Fimia, Gian Maria, Tripodi, Marco, Poccia, Fabrizio

    Published in International immunology (01-01-2006)
    “…Hepatitis C virus (HCV) has evolved complex strategies to evade host immune responses and establish chronic infection. Since human Vγ9Vδ2 T lymphocytes play a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C by Baiocchini, Andrea, Del Nonno, Franca, Taibi, Chiara, Visco-Comandini, Ubaldo, D’Offizi, Gianpiero, Piacentini, Mauro, Falasca, Laura

    Published in Scientific reports (19-06-2019)
    “…The sinusoidal endothelial cells present in the liver (LSECs) are tipically characterized by the presence of pores (fenestrae). During some pathological…”
    Get full text
    Journal Article